Literature DB >> 27026583

Challenges to prevent secondary fractures in patients with hip fractures in Joetsu Myoko, Japan through the increased use of osteoporosis treatment and collaboration with family doctors.

Nobuaki Suzuki1, Katsumitsu Arai2, Saizo Kon1, Kayo Yamanaka1, Hiroshi Otsuka1, Masahiro Koizumi1, Noboru Hosaka1, Masahiko Tsuchiya1, Tomoharu Mochizuki1, Tatsuya Kuraishi1, Takayuki Murayama1, Hideki Tashi1, Naoki Oike1, Masashi Wakasugi1, Yuki Takahashi1, Masato Nakadai1, Naoto Endo3.   

Abstract

The Niigata Prefectural Central Hospital (NPCH) is one of the main hospitals for the cities of Joetsu and Myoko, Niigata Prefecture, Japan, an area with a population of 240,141, of whom 26.7 % were aged ≥65 years in 2009. In the NPCH, patients with hip fractures are admitted to an orthopedic ward within 4 h, 89.2 % of patients are operated on within 48 h during working hours, and the prevalence of pressure ulcers is 1.5 %. To reduce the incidence of hip fractures, two major challenges emphasizing secondary fracture prevention were initiated in 2012. The first challenge used a team approach-hospital pharmacists asked patients about their drug use histories, orthopedic surgeons began drug therapy for osteoporosis after explaining to patients its importance for the prevention of secondary hip fractures, nurses assessed the risk of falling, and physiotherapists conducted rehabilitation with the aim of preventing falls. The second challenge focused on maintaining treatment for osteoporosis after discharge, when patients were under the oversight of family doctors. The percentages of patients with primary hip fractures who were taking anti-osteoporosis medications at the time of discharge in 2009, 2012, 2013 and 2014 were 21, 33, 41, and 43 %, respectively. The 12-month incidences of hip fractures on the unaffected side in 2009, 2012, 2013 and 2014 were 7.4, 2.2, 0, and 2.4 %, respectively, and the 24-month incidences of such fractures in 2009, 2012 and 2013 were 12, 7.6, and 5.2 %, respectively. Our challenges were effective at decreasing the incidence of secondary fractures.

Entities:  

Keywords:  Hip fracture; Osteoporosis treatment; Prevention; Secondary fracture; Team approach

Mesh:

Year:  2016        PMID: 27026583     DOI: 10.1007/s00774-016-0758-7

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  18 in total

1.  Risk factors for second hip fractures among elderly patients.

Authors:  Sugao Mitani; Masato Shimizu; Masahiro Abo; Hiroshi Hagino; Youichi Kurozawa
Journal:  J Orthop Sci       Date:  2010-04-01       Impact factor: 1.601

2.  Factors associated with mortality following hip fracture in Japan.

Authors:  Shigeyuki Muraki; Seizo Yamamoto; Hideaki Ishibashi; Kozo Nakamura
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

3.  Incidence of hip fracture over a 10-year period (1991-2000): reversal of a secular trend.

Authors:  T Chevalley; E Guilley; F R Herrmann; P Hoffmeyer; C-H Rapin; R Rizzoli
Journal:  Bone       Date:  2007-01-04       Impact factor: 4.398

4.  Mortality after hip fracture with vertebral compression fracture is poor.

Authors:  Norio Imai; Naoto Endo; Tadashi Hoshino; Ken Suda; Dai Miyasaka; Tomoyuki Ito
Journal:  J Bone Miner Metab       Date:  2014-12-14       Impact factor: 2.626

5.  Fracture liaison service: impact on subsequent nonvertebral fracture incidence and mortality.

Authors:  Kirsten M B Huntjens; Tineke A C M van Geel; Joop P W van den Bergh; Svenhjalmar van Helden; Paul Willems; Bjorn Winkens; John A Eisman; Piet P Geusens; Peter R G Brink
Journal:  J Bone Joint Surg Am       Date:  2014-02-19       Impact factor: 5.284

6.  Sequential change in quality of life for patients with incident clinical fractures: a prospective study.

Authors:  H Hagino; T Nakamura; S Fujiwara; M Oeki; T Okano; R Teshima
Journal:  Osteoporos Int       Date:  2008-10-03       Impact factor: 4.507

7.  Recent trends in the incidence and lifetime risk of hip fracture in Tottori, Japan.

Authors:  H Hagino; K Furukawa; S Fujiwara; T Okano; H Katagiri; K Yamamoto; R Teshima
Journal:  Osteoporos Int       Date:  2008-07-17       Impact factor: 4.507

8.  Antifracture efficacy and reduction of mortality in relation to timing of the first dose of zoledronic acid after hip fracture.

Authors:  Erik Fink Eriksen; Kenneth W Lyles; Cathleen S Colón-Emeric; Carl F Pieper; Jay S Magaziner; Jonathan D Adachi; Lars Hyldstrup; Chris Recknor; Lars Nordsletten; Catherine Lavecchia; Huilin Hu; Steven Boonen; Peter Mesenbrink
Journal:  J Bone Miner Res       Date:  2009-07       Impact factor: 6.741

9.  Beneficial effect of risedronate for preventing recurrent hip fracture in the elderly Japanese women.

Authors:  M Osaki; K Tatsuki; T Hashikawa; T Norimatsu; K Chiba; S Motokawa; I Furuichi; Y Doiguchi; K Aoyagi; H Shindo
Journal:  Osteoporos Int       Date:  2011-03-11       Impact factor: 4.507

10.  The effect of early surgery after hip fracture on 1-year mortality.

Authors:  Paola Colais; Mirko Di Martino; Danilo Fusco; Carlo Alberto Perucci; Marina Davoli
Journal:  BMC Geriatr       Date:  2015-10-28       Impact factor: 3.921

View more
  3 in total

Review 1.  Secondary prevention of fragility fractures in Asia Pacific: an educational initiative.

Authors:  P R Ebeling; D-C Chan; T C Lau; J K Lee; T Songpatanasilp; S H Wong; F L Hew; R Sethi; M Williams
Journal:  Osteoporos Int       Date:  2019-12-01       Impact factor: 4.507

Review 2.  The Clinical Impact of Fracture Liaison Services: A Systematic Review.

Authors:  David W Barton; Amit S Piple; C Taylor Smith; Sterling A Moskal; Jonathan J Carmouche
Journal:  Geriatr Orthop Surg Rehabil       Date:  2021-01-11

3.  Romosozumab or alendronate for fracture prevention in East Asian patients: a subanalysis of the phase III, randomized ARCH study.

Authors:  E M C Lau; R Dinavahi; Y C Woo; C-H Wu; J Guan; J Maddox; C Tolman; W Yang; C S Shin
Journal:  Osteoporos Int       Date:  2020-02-11       Impact factor: 4.507

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.